Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiac Safety Evaluation of Lansoprazole/Domperidone 30/30 mg Sustained Release Capsule Formulation

NCT03355170 is registered in ClinicalTrials.gov with Neutec Ar-Ge San ve Tic A.Ş as lead sponsor.

NCT NCT03355170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03355170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiac Safety Evaluation of Lansoprazole/Domperidone 30/30 mg Sustained Release Capsule Formulation
Lead sponsor
Neutec Ar-Ge San ve Tic A.Ş
Phase
Phase 4
Overall status
Withdrawn
Start date
March 1, 2018
Completion date
January 1, 2019
Enrollment
0 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac event, gerd, safety issues